Patents for C12R 1 - Micro-organisms (92,025)
01/2001
01/10/2001EP1067192A1 L-lysine producing coryneform bacteria and methods for the production of L-lysine
01/10/2001EP1067191A2 DNA coding for mutant isopropylmalate synthase, L-leucine-producing microorganism and method for producing L-leucine
01/10/2001EP1066399A1 Process for the microbial conversion of phytosterols to androstenedione and androstadienedione
01/10/2001EP1066393A1 Expression system for producing proteins
01/10/2001EP1066392A1 Vectors for gene mutagenesis and gene discovery
01/10/2001EP1066386A2 Method for reduction of fusel oils in alcoholic beverages and food products
01/10/2001EP1066384A1 Method for increasing the phenoxy propionic acid hydroxylation rate
01/10/2001EP1066376A1 Bacteria attenuated by a non-reverting mutation in each of the aroc, ompf and ompc genes, useful as vaccines
01/10/2001EP1066028A2 Methods and devices for modulating the immune response
01/10/2001EP0764209B1 Albumin expression in yeast
01/10/2001EP0672115B1 Method of clonal growth of streptococcus pneumoniae
01/10/2001CN1279722A Gram-positive microorganism formate transporters
01/10/2001CN1279721A Multiply-substituted protease variants
01/10/2001CN1279720A Multiply-substituted protease variants with altered net charge for use in detergents
01/10/2001CN1279715A Protease variants and compositions
01/10/2001CN1279714A Epoxide hydrolase
01/10/2001CN1279712A Lactobacillus helveticus bacterium having high capability of producing tripentide, fermented milk product, and preparing process thereof
01/10/2001CN1279692A Anti-idiotype monoclonal antibodise, their use in active immunotherapy of malignant tumors and compositions containing them
01/10/2001CN1279614A Antistress agents and functional foods
01/09/2001US6172279 Plant gene construct encoding a protein capable of disrupting the biogenesis of viable pollen
01/09/2001US6172215 Nucleotide sequences which hybridize preferentially to microorganismal nucleotide sequences; screening for preferential microorganisms which cause gastrointestinal disorders
01/09/2001US6172200 Monoclonal antibody that preferentially binds protein; for use as diagnostic tool in analyzing embryonic development and cellular regulation; for the detection of modulators of gene expression
01/09/2001US6172199 Human ubiquitin-conjugating enzyme
01/09/2001US6172194 ARF-p19, a novel regulator of the mammalian cell cycle
01/09/2001US6172193 Escape mutant of the surface antigen of hepatitis B virus
01/09/2001US6172192 Polypeptide or peptide associated microorganism infection; for diagnosis and prevention protozoan infection of mammals
01/09/2001US6172184 Genetically engineered protein; for generating disease resistance plants and to amplify plant propagation; for biological pest control
01/09/2001US6172030 Containing protopectinase; cleaning mud
01/09/2001US6171846 Culturing cells which are blocked in the synthesis of virginimycins; mutating genes in target microorganism and recovering cells with mutated target genes
01/09/2001US6171845 Mutant E. coli kiz strains for production of pantothenic acid
01/09/2001US6171842 Chimeric serine proteases
01/09/2001US6171841 DNA coding for serine/threonine kinase
01/09/2001US6171840 LacC from streptococcus pneumoniae
01/09/2001US6171838 ratB
01/09/2001US6171830 Efficient purification of mycolic acids, salts or derivatives by dissolving mixture in bi-phasic solvent, subjecting to countercurrent distribution separation with sufficient cycles, then recovering
01/09/2001US6171825 Culturing mammalian host cells in medium supplemented with copper ions and free of plasma-derived protein and polyol supplements
01/09/2001US6171823 Transforming bacteria having cell membranes with recombinant vector encoding a fusion protein of n-terminal prepropeptide of acrhomobacter lyticus protease i fused to desired protein, culturing, and recovering proteins
01/09/2001US6171808 Mutant luciferases
01/09/2001US6171806 Isolated peptide defined by SEQ ID NO: 17 and uses thereof
01/09/2001US6171803 Drug screening for allergy treatments by engineering expression of alpha, beta, and gamma subunits of receptor in host cell, incubating with candidate inhibitor, and analyzing for cell expression or cell activation
01/09/2001US6171799 Immunoassay detection of a v beta 5.3 t cell by contacting tissue sample with a monoclonal antibody which reacts to variable region of beta chain of the receptor; diagnosis and treatment of rheumatoid arthritis
01/09/2001US6171781 NF-AT polypeptides and polynucleotides
01/09/2001US6171598 GTP cyclohydrolase II (RIBA)
01/09/2001CA2313374A1 Immobilized lipase
01/07/2001CA2310890A1 L-lysine-producing corynebacteria and process for the preparation of l-lysine
01/07/2001CA2310870A1 L-lysine-producing corynebacteria and process for the preparation of l-lysine
01/04/2001WO2001000857A1 Delivery system
01/04/2001WO2001000852A1 Regulation of carbon assimilation
01/04/2001WO2001000846A2 Linoleate isomerase
01/04/2001WO2001000844A2 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production
01/04/2001WO2001000843A2 Corynebacterium glutamicum genes encoding metabolic pathway proteins
01/04/2001WO2001000842A2 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation
01/04/2001WO2001000839A1 Tetanus toxin polypeptides
01/04/2001WO2001000837A1 Basb111 polypeptide and polynucleotide from moraxella catharrhalis
01/04/2001WO2001000832A1 Methods for making apo-2 ligand using divalent metal ions
01/04/2001WO2001000805A2 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
01/04/2001WO2001000804A2 Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins
01/04/2001WO2001000793A1 Method for producing human cloned embryos by employing inter-species nuclear transplantation technique
01/04/2001WO2001000668A1 Extraction of integral membrane proteins
01/04/2001WO2001000627A1 New indolocarbazole alkaloids from a marine actinomycete
01/04/2001WO2001000045A1 Drinks and foods capable of eliminating helicobacter pylori
01/04/2001WO2000063237A3 Pseudomycin analogs
01/04/2001WO2000061611A3 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
01/04/2001WO2000058444A3 Adaptation of virus to vertebrate cells
01/04/2001WO1999020723A3 Multiply-substituted protease variant and amylase variant-containing cleaning compositions
01/04/2001CA2383875A1 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production
01/04/2001CA2383865A1 Corynebacterium glutamicum genes encoding metabolic pathway proteins
01/04/2001CA2380871A1 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation
01/04/2001CA2380870A1 Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins
01/04/2001CA2380863A1 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
01/04/2001CA2377585A1 Methods for making apo-2 ligand using divalent metal ions
01/04/2001CA2377534A1 Delivery system
01/04/2001CA2377531A1 Basb111 polypeptide and polynucleotide from moraxella catarrhalis
01/04/2001CA2377488A1 Regulation of carbon assimilation
01/04/2001CA2377473A1 Linoleate isomerase
01/04/2001CA2334953A1 Method for producing human cloned embryos by employing inter-species nuclear transplantation technique
01/03/2001EP1065271A1 Phagemide for screening antibodies
01/03/2001EP1065215A1 Homomeric and heteromeric AMPA receptors
01/03/2001EP1064952A2 Methods and compositions for the suppression of neu mediated transformations
01/03/2001EP1064366A1 $i(STAPHYLOCOCCUS AUREUS) GENES AND POLYPEPTIDES
01/03/2001EP1064359A2 Phenol oxidizing enzyme enzymes
01/03/2001EP1064309A2 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue
01/03/2001EP1064306A1 $i(NEPHRIN) GENE AND PROTEIN
01/03/2001EP1064303A1 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
01/03/2001EP1063882A1 Skin equivalent and methods of forming and using same
01/03/2001EP0816506B1 System for the expression of heterologous antigens as fusion proteins
01/03/2001EP0637244B1 A strain of streptomyces avermitilis glycosylates avermectin compounds
01/03/2001CN1278864A Genetically modified tumor-targeted bacteria with reduced virulence
01/03/2001CN1278736A Hmanized antibodies to human gp39, compositions containing and therapeutic use thereof
01/03/2001CN1060216C Improved methods for the preparation of endotoxinbinding proteins
01/03/2001CN1060212C Dictyestelium dipeptidlaminopeptidase, its separation method and use thereof
01/02/2001US6169175 Dna sequence encoding a variant m2 polypeptide of influenza a having a deletion of a domain, thus causing a reduction in hydrophobicity and an increase solubility in aqueous buffers
01/02/2001US6169174 Dna coding for a protein of defined amino acid sequence which controls fiber formation; for improvements in textile, paper and food industries
01/02/2001US6169167 Antibodies to ligands for HEK4 receptors
01/02/2001US6169073 An oligopeptide or polypeptide for activating dna binding of wild-type p53 and select tumor-derived p53 mutants; use in therapy of cancer and other disorders characterized by excessive proliferation of certain cells and tissues
01/02/2001US6169070 Mer receptor activation by gas6
01/02/2001US6169068 Treating lung disease or disorder by inhalating a protein
01/02/2001US6168947 Nematophagous fungus Esteya vermicola
01/02/2001US6168940 Protein having ethylenediamine-N,N′-disuccinic acid:ethylenediamine lyase acitivity and gene encoding the same
01/02/2001US6168939 Endopeptidase produced by Lactobacillus helveticus